• 

  Amyloid Hypothesis Twist: Restoring ‘Good’ Beta-Amyloid to Treat Alzheimer’s
• 

  Medicare Is Deciding Now Whether To Cover Aduhelm—And All the Similar Drugs to Follow
• 

  FDA Head Calls for Investigation Into Controversial Aduhelm Approval
• 

  FDA Limits the Use of Aduhelm After Criticisms of Broad Approval
• 

  Lynn Casteel Harper: Suffering No More—Reimagining Dementia for a Post-COVID World
• 

  A Virtual Microscope for Alzheimer’s Earns FDA ‘Breakthrough’ Designation
• 

  Improving Health and Quality of Life for Long-Term Care Residents: Sit Less, Move More
• 

  Aging in Place: Modifications for Safer Homes
• 

  A Reason To Reach Out: The Therapeutic Power of a Phone Call
• 

  Cognitive Super-Agers, a True Love Story, and Other June Reads
• 

  Emerging Research: Sports Concussions Affect Men and Women Differently
• 

  Hollywood’s Dementia Stories Highlight Impact of Dementia As Its Prevalence Grows
• 

  Op-Ed: After a Woman With Dementia Is Assaulted By Police, A Closer Look at the Root Causes of Elder Abuse
• 

  FDA Speeds Up Process for Two More Anti-Amyloids
• 

  The Questions Doctors Are Getting About Aduhelm Right Now—And Their Answers

Previous818283Next